Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure.
Steinberg BA, Mentz RJ. Return on Investment in Implantable Devices: Cardiac Resynchronization Therapy in Mildly Symptomatic Heart Failure. JACC Heart Fail. 2017 03; 5(3):213-215.